Anthem, Cigna, CVS Say PBMs Are Weathering COVID-19

For PBMs, 2020 has been far from business as usual, given the myriad ways the COVID-19 pandemic has changed how people interact with the health care system. However, during their second-quarter earnings conference calls, companies that own some of the largest PBMs emphasized that they are largely satisfied with how the PBM segments of their businesses are performing.

Anthem, Inc. Chief Financial Officer John Gallina, for example, said during the insurer’s July 29 earnings call that “IngenioRx is actually doing quite well, and has really done a nice job of meeting our expectations.”

© 2024 MMIT
Leslie Small

Leslie Small

Leslie has been reporting and editing in various journalism roles for nearly a decade. Most recently, she was the senior editor of FierceHealthPayer, an e-newsletter covering the health insurance industry. A graduate of Penn State University, she previously served in editing roles at newspapers in Pennsylvania, Virginia and Colorado.

Related Posts

pills
April 25

Expiring Policies Threaten Progress on Opioid Use Disorder Med Uptake

READ MORE
businessman-viewing-news-update-journalism-headline-on-a-laptop
April 25

News Briefs: CarelonRx Launches New Specialty Offering

READ MORE
iv-injection
April 25

Analysis Tallies Premium Impact of Provider Markups on Specialty Drugs

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today